Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities of continuing operations:
Net loss	$ (16,766,738)	$ (10,222,982)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	593,438	814,849
Amortization of debt discount	2,194,302	2,061,470
Provision for doubtful accounts	0	2,195
Provision for excess or obsolete inventory	5,321	0
Common stock issued for financing costs	0	10,000
Common stock issued in exchange for fees and services	116,737	1,274,135
Convertible notes issued for financing costs	0	59,633
Deferred taxes	466,089	65,925
Derivative expense	1,052,350	0
Goodwill impairment	11,340,115	276,448
Intangible asset impairment	0	106,350
Stock based compensation	315,332	493,563
Amortization of rights-of-use assets	365,636	304,560
Loss on disposal of property and equipment	2,237	2,692
Loss on extinguishment of debt	0	718,267
Loss on settlement of derivative liability	143,598	0
Gain on change in fair value of derivative liability	(49,047)	0
Gain on change in fair value of contingent purchase consideration	(5,586,493)	0
Changes in operating assets and liabilities:
Accounts receivable	(192,730)	(382,843)
Inventory	(6,253)	22,571
Prepaid expenses and other current assets	(147,545)	(37,523)
Other assets	(974,380)	(457,065)
Accounts payable	342,182	(770,656)
Accrued liabilities	(21,375)	(1,149,202)
Advanced payments and deferred revenues	170,937	(562,625)
Income taxes payable and other noncurrent liabilities	44,055	(79,581)
Operating lease liability	(383,888)	(310,683)
Related party payables	0	(95,741)
Net cash used in operating activities	(6,976,120)	(7,856,243)
Cash flows from investing activities:
Cash consideration for acquisition of business	0	(373,592)
Purchase of fixed assets	(104,715)	(43,504)
Proceeds from sale of property and equipment	13,418	0
Net cash used in investing activities	(91,297)	(417,096)
Cash flows from financing activities:
Proceeds from issuance of preferred stock, net of issuance costs	0	1,050,000
Proceeds from exercise of common stock purchase warrants, net of issuance costs	279	33,001
Proceeds from issuance of common stock, net of issuance costs	4,360,330	10,220,351
Proceeds from issuance of convertible notes	1,444,000	4,516,700
Repayments of convertible notes	(148,907)	(1,092,447)
Repayments of loans payable	(36,834)	(54,038)
Repayment of settlement of derivative liability upon note conversion	(1,146,901)	0
Net cash provided by financing activities	4,471,967	14,673,567
Effect of exchange rates on cash and cash equivalents	(63,535)	9,633
Net increase (decrease) in cash and cash equivalents	(2,658,985)	6,409,861
Cash and cash equivalents at beginning of period	6,530,161	120,300
Cash and cash equivalents at end of period	3,871,176	6,530,161
Supplemental disclosure of cash flow information:
Cash paid for interest	41,763	139,627
Cash paid for income taxes	0	0
Supplemental disclosure of non-cash investing and financing activities:
Common stock issued related to acquisition of business	0	5,421,962
Common stock issued related to Series C preferred stock dividend	833,739	0
Common stock issued for financing costs incurred in connection with convertible and promissory notes	0	29,750
Common stock warrants issued in connection with convertible promissory notes	363,329	1,895,078
Contingent purchase consideration	0	5,586,493
Conversion of convertible notes and accrued interest into common stock	0	2,048,797
Conversion of convertible notes and accrued interest into preferred stock	0	1,702,246
Debt issued related to acquisition of a business	0	278,000
Discount for beneficial conversion features on convertible notes	0	318,616
Preferred stock dividend payable on convertible preferred stock	$ 371,799	$ 0